NDC 0310-0512 – Calquence
Acalabrutinib 100 mg/1 · Capsule, Gelatin Coated · Oral
Product NDC0310-0512
Product details
- Brand name
- Calquence
- Generic name
- Acalabrutinib
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- Capsule, Gelatin Coated
- Route
- Oral
- Marketing category
- NDA · NDA210259
- Marketed since
- October 31, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Kinase Inhibitor
Active ingredients
- Acalabrutinib 100 mg/1
Package NDC codes (0)
| Package NDC | Description | Since |
|---|